Accumulation of phosphorylated alpha-synuclein in aging human brain.
暂无分享,去创建一个
Hideo Fujiwara | Takeshi Iwatsubo | Yuko Saito | Shigeo Murayama | Masato Hasegawa | T. Iwatsubo | M. Hasegawa | S. Murayama | H. Nagura | M. Sawabe | H. Fujiwara | T. Arai | A. Kawashima | Tomio Arai | Motoji Sawabe | Yuko Saito | H. Yamanouchi | Akiko Kawashima | Nyoka N Ruberu | Shunichi Koyama | Hiroshi Nagura | Hiroshi Yamanouchi | S. Koyama | Nyoka N. Ruberu | Hideo Fujiwara | Shun‐ichi Koyama
[1] T. Kato,et al. Spinal cord lesions in progressive supranuclear palsy: some new observations , 1986, Acta Neuropathologica.
[2] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[3] J. Trojanowski,et al. Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions* , 2002, The Journal of Biological Chemistry.
[4] S. Murayama,et al. Severe Involvement of Ambient Gyrus in Dementia with Grains , 2002, Journal of neuropathology and experimental neurology.
[5] J. Trojanowski,et al. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases , 2002, Annals of neurology.
[6] J. Trojanowski,et al. Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam , 2002 .
[7] Udo Rüb,et al. Where Does Parkinson Disease Pathology Begin in the Brain? , 2002, Journal of neuropathology and experimental neurology.
[8] E. Masliah,et al. α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.
[9] G. Asano,et al. α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation , 2001, Brain Research.
[10] E. Mori. [Dementia with Lewy bodies]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[11] I. Kanazawa,et al. Widespread expression of α-synuclein and τ immunoreactivity in Hallervorden–Spatz syndrome with protracted clinical course , 2000, Journal of the Neurological Sciences.
[12] I. Kanazawa,et al. Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course. , 2000, Journal of the neurological sciences.
[13] I G McKeith,et al. Report of the second dementia with Lewy body international workshop , 1999, Neurology.
[14] I G McKeith,et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. , 1999, Brain : a journal of neurology.
[15] K. Ishii,et al. Regional cerebral blood flow difference between dementia with Lewy bodies and AD , 1999, Neurology.
[16] K. Iwanaga,et al. Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases , 1999, Neurology.
[17] J Q Trojanowski,et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.
[18] Hiroaki Kazui,et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography , 1997, Neuroscience Letters.
[19] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[20] K. Jellinger,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.
[21] Michel Goedert,et al. Identification of two distinct synucleins from human brain , 1994, FEBS letters.
[22] K. Davis,et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. , 1994, Neuroreport.
[23] J. Saint-Cyr,et al. Parkinson's disease and dementia , 1989, Neurology.
[24] H. Braak,et al. Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes , 1987, Neuroscience Letters.
[25] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.